Researchers introduced the PREVENT risk age equations to help determine risk of cardiovascular disease. (JAMA Cardiology) A ...

As Sky News research revealed thousands of severely obese patients are facing severely delayed treatment, here we look at the ...

A post hoc analysis of the SUMMIT trial, published in JACC, reveals that baseline body mass index (BMI) and fat distribution ...

Triggered Brand has agreed to pay $18,500 out of a $300,000 judgment after Attorney General William Tong sued the company in ...

Facebook posts reveal more GI side effects from semaglutide drugs like Ozempic than Mounjaro, offering new insights into ...

The updated standard replaces three previous guidelines and reflects the latest thinking on tackling obesity through the ...

People using weight loss medication have been told it's not a "quick fix" with many at risk of regaining their lost weight.

Patients ending obesity medication or finishing a weight management programme should be offered support to help keep the ...

People using weight loss medication have been warned it is not a "quick fix" with many at risk of regaining their lost weight ...

Digital health company Noom has started offering lower doses of GLP-1 agonist semaglutide, the active ingredient in Novo Nordisk's weight-loss drug Wegovy, at a knock-down price. The 'microdose' ...

Patients coming off Wegovy or Mounjaro should have support and advice for at least a year afterwards, NHS told.

Dear E.M.: Obstructive sleep apnea is when a person stops breathing during sleep due to obstruction of their airway. Some ...